In the first study by Luka et al., the exclusivity of cancer-specific MUC5AC to colon and pancreatic cancers was confirmed in tumor cell lines, tumor, normal tissues, and in the serum of cancer patients. This evidence concerns the gene MUC5AC and neoplasm.